AbbVie Inc. (ABBV)

AbbVie Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	5,993	4,863	11,836	11,542	4,616	7,882
Depreciation & Amortization	8,645	8,698	8,467	8,521	6,471	2,017
Share-Based Compensation	782	747	671	692	753	430
Other Operating Activities	7,266	8,531	3,969	2,022	5,748	2,995
Operating Cash Flow	22,686	22,839	24,943	22,777	17,588	13,324
Operating Cash Flow Growth	-6.36%	-8.44%	9.51%	29.50%	32.00%	-0.77%
Capital Expenditures	-795	-777	-695	-787	-798	-552
Acquisitions	-10,259	-1,223	-794	-1,902	-39,610	-1,135
Change in Investments	-25	-22	92	-21	1,464	2,116
Other Investing Activities	-19	13	774	366	1,387	167
Investing Cash Flow	-11,098	-2,009	-623	-2,344	-37,557	596
Dividends Paid	-10,650	-10,539	-10,043	-9,261	-7,716	-6,366
Share Issuance / Repurchase	-1,099	-1,792	-1,225	-690	-769	-621
Debt Issued / Paid	11,928	-4,187	-12,433	-8,414	-2,703	25,823
Other Financing Activities	-390	-704	-1,102	-674	-313	-128
Financing Cash Flow	-211	-17,222	-24,803	-19,039	-11,501	18,708
Exchange Rate Effect	-21	5	-62	-97	-5	7
Net Cash Flow	11,356	3,613	-545	1,297	-31,475	32,635
Free Cash Flow	21,891	22,062	24,248	21,990	16,790	12,772
Free Cash Flow Growth	-6.93%	-9.02%	10.27%	30.97%	31.46%	-0.13%
Free Cash Flow Margin	40.24%	40.62%	41.77%	39.13%	36.66%	38.39%
Free Cash Flow Per Share	12.38	12.48	13.69	12.42	10.07	8.62

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).